7L9-16329-63299 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Registered in v-safe
2021-03-23
Dose 1 — Pfizer-BioNTech
2021-03-23
Survey response — day 0, dose 1
MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Headache, Nausea

Free text: Metallic taste in mouth

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness, Nausea

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-06
Survey response — day 14, dose 1
MedDRA: Fatigue, Headache — Feeling: Fair

Free text: Fatigue and headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-19
Dose 2 — Pfizer-BioNTech
2021-04-20
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-26
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-31
Survey response — day 42, dose 2
MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Sinus infection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-31
Report sent to call center — day 42, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-19
Survey response — 3 months, dose 2
MedDRA: Office visit, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Rash; presumed to be vasculitis over bottom half of legs. Painful. · Healthcare visit (other): Primary and specialist care

MedDRA releases: 2024-11 · check-in free text available
2021-07-19
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-24
Call 1 — Left Voicemail
2021-08-25
Dose 3 — Pfizer-BioNTech
2021-10-20
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-02-23
Survey response — 6 months, dose 3
MedDRA: Heavy menstrual bleeding — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Heavy menstrual cycle

MedDRA releases: 2024-11 · check-in free text available
2022-02-23
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-24
Call 1 — Left Voicemail
2022-08-27
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Pfizer-BioNTech
2	2021-04-19	Pfizer-BioNTech
3	2021-08-25	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-31	Unsuccessful
2021-07-19	Unsuccessful
2022-02-23	Unsuccessful

Free text

Release 6 — day 0, dose 1

2021-03-23

Systemic reaction (other): Metallic taste in mouth

Release 7 — day 14, dose 1

2021-04-06

Symptoms: Fatigue and headache

Release 8 — day 42, dose 2

2021-05-31

Symptoms: Sinus infection

Release 9 — 3 months, dose 2

2021-07-19

Symptoms: Rash; presumed to be vasculitis over bottom half of legs. Painful.

Healthcare visit (other): Primary and specialist care

Release 11 — 6 months, dose 3

2022-02-23

Symptoms: Heavy menstrual cycle

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Rash	·	·	✓
SD	Sinusitis	✓	✓	✓
SRO	Dysgeusia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release